Case Report (n=1)
No
Highlights the diagnostic dilemma between catatonia and neuroleptic malignant syndrome and the importance of detailed history and symptom management.
Answers are grounded in this paper and cite their sources.
May aid catatonia-NMS differentiation via detailed assessment; leaves open validation in prospective studies.
Catatonia is a syndrome, comprised of symptoms such as motor immobility, excessive motor activity, extreme negativism, and stereotyped movements. Neuroleptic is able to induce catatonia like symptoms, that is, the neuroleptic malignant syndrome (NMS). In NMS, patients typically show symptoms such as an altered mental state, muscle rigidity, tremor, tachycardia, hyperpyrexia, leukocytosis, and elevated serum creatine phosphorous kinase. Several researchers have reported studies on catatonia and the association between catatonia and NMS, but none were from this part of the eastern India. In our case, we observed overlapping symptoms of catatonia and NMS; we wish to present a case of this diagnostic dilemma in a patient with catatonia, where a detailed history, investigation, and symptom management added as a great contribution to the patient's rapid improvement.
No takes yet. Share an insight, caveat, or question.
Sahoo et al. (2014) conducted a case report in Catatonia and Neuroleptic Malignant Syndrome (n=1). Aripiprazole and bromocriptine was evaluated on Clinical improvement.
Synapse has enriched 10 related papers. Consider them for comparative context: